gene_symbol
BCL2
hgnc_id
HGNC:990
binding_type
other
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Venetoclax inhibits anti-apoptotic BCL-2, releasing BH3 activators to trigger BAX/BAK activation, mitochondrial outer membrane permeabilization, cytochrome c release, and caspase-dependent apoptosis in BCL-2–dependent cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
BH3 mimetic; binds the BH3-binding hydrophobic groove to inhibit anti-apoptotic function
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06471738
disease_id_num_tar_ref
3734
drug_id_num_tar_ref
10098